Malin Corporation | MLC - Operating Expenses



Malin Corporation reported EUR1.1M in Operating Expenses for its fiscal semester ending in December of 2024.


Operating Expenses Change Date
Alaunos Therapeutics USD 759K 391K Dec/2024
ALKERMES USD 297.68M 4.96M Jun/2025
Avita Medical AUD 28.36M 2.44M Dec/2024
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Eurofins Scientific SE EUR 2.83B 182.1M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 1.04B 113M Jun/2025
Organon & Co USD 1.27B 144M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Tectonic Therapeutic USD 22.33M 8.34M Jun/2025
Viatris USD 3.4B 2.88B Jun/2025
Xeris Pharmaceuticals USD 67.06M 8.64M Jun/2025